Back to Screener

Picard Medical, Inc. (PMI)

Price$0.90

Favorite Metrics

Price vs S&P 500 (26W)-99.09%
Price vs S&P 500 (4W)-28.88%
Market Capitalization$69.69M

All Metrics

Price vs S&P 500 (YTD)-51.17%
10-Day Avg Trading Volume0.12M
EPS (Annual)$-0.29
ROI (Annual)-92.97%
Gross Margin (Annual)-2.55%
Cash / Share (Quarterly)$0.01
ROA (Last FY)-173.92%
Cash Flow / Share (Annual)$-0.16
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)-1.86x
EPS Incl Extra (Annual)$-0.29
Current Ratio (Annual)0.28x
Quick Ratio (Quarterly)0.04x
3-Month Avg Trading Volume0.64M
P/S Ratio (Annual)15.87x
Asset Turnover (Annual)0.36x
52-Week High$13.68
EPS Excl Extra (Annual)$-0.29
26-Week Price Return-90.34%
Quick Ratio (Annual)0.02x
13-Week Price Return-47.63%
Total Debt / Equity (Annual)0.06x
Current Ratio (Quarterly)0.21x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-479.85%
Cash / Share (Annual)$0.00
3-Month Return Std Dev107.54%
ROE (Last FY)-98.23%
EPS Basic Excl Extra (Annual)$-0.29
Revenue / Share (Annual)$0.06
Year-to-Date Return-47.03%
5-Day Price Return-2.42%
EPS Normalized (Annual)$-0.29
Net Profit Margin (Annual)-479.50%
Month-to-Date Return-10.87%
EBITD / Share (Annual)$-0.18
Operating Margin (Annual)-312.28%
LT Debt / Equity (Annual)0.00x
Price vs S&P 500 (13W)-50.49%
Beta0.00x
52-Week Low$0.90

Industry Peers — Surgical & Medical Instruments(109)

SymbolP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
PMIPicard Medical, Inc.
$0.90
SYKStryker Corporation
5.17x11.84%64.57%19.43%$338.34
BSXBoston Scientific Corp.
4.58x15.16%69.01%18.00%$60.99
MMM3M Company
3.21x-4.97%39.92%18.55%$151.40
MDLNMedline Inc. Class A common stock
2.20x26.44%7.78%$48.26
BDXBecton, Dickinson and Co.
2.06x6.32%46.42%12.15%$158.64
RMDResMed Inc.
6.07x11.72%60.85%33.70%$226.14
DXCMDexCom, Inc.
5.33x19.33%62.09%19.56%$64.62
WSTWest Pharmaceutical Services, Inc.
6.29x7.44%35.91%19.03%$278.00
PODDInsulet Corporation
5.19x24.53%71.63%12.92%$200.87
PENPenumbra, Inc.
9.24x20.16%67.14%13.48%$329.71

About

Picard Medical develops and manufactures implantable Total Artificial Heart (TAH) systems designed to replace the function of a failed human heart. Through its wholly owned medical technology subsidiary, the company focuses on serving patients with advanced heart failure who have limited treatment options.